Literature DB >> 17904849

Synthesis of 2'-O-modified adenosine building blocks and application for RNA interference.

Dalibor Odadzic1, Jesper B Bramsen, Romualdas Smicius, Claus Bus, Jørgen Kjems, Joachim W Engels.   

Abstract

RNA-interference has been recognized as a powerful tool to control gene function and has been used for gene silencing by knocking down mRNA. Chemically modified RNAs, especially 2'-O-modification, successfully improved their physicochemical and pharmaceutical properties such as stability, nuclease resistance and delivery. Here, we report the synthesis of adenosine building blocks with different 2'-tethered modifications like aminoethyl and guanidinoethyl and show that they are compatible with RNAi function. They enhance the half life of the siRNA in serum suggesting that these modifications can enhance the pharmacokinetic properties and knock down activity of siRNAs in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17904849     DOI: 10.1016/j.bmc.2007.09.019

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  15 in total

1.  RNA interference: A futuristic tool and its therapeutic applications.

Authors:  Anghesom Ambesajir; Atul Kaushik; Jeevan J Kaushik; Sham T Petros
Journal:  Saudi J Biol Sci       Date:  2012-08-17       Impact factor: 4.219

Review 2.  Current Transport Systems and Clinical Applications for Small Interfering RNA (siRNA) Drugs.

Authors:  Fang Liu; Chunfang Wang; Yuantao Gao; Xiao Li; Feng Tian; Yongtao Zhang; Mingyang Fu; Pengfei Li; Yali Wang; Fei Wang
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

Review 3.  Progress toward in vivo use of siRNAs-II.

Authors:  Garrett R Rettig; Mark A Behlke
Journal:  Mol Ther       Date:  2011-12-20       Impact factor: 11.454

4.  Small-Molecule CD4-Mimics: Structure-Based Optimization of HIV-1 Entry Inhibition.

Authors:  Bruno Melillo; Shuaiyi Liang; Jongwoo Park; Arne Schön; Joel R Courter; Judith M LaLonde; Daniel J Wendler; Amy M Princiotto; Michael S Seaman; Ernesto Freire; Joseph Sodroski; Navid Madani; Wayne A Hendrickson; Amos B Smith
Journal:  ACS Med Chem Lett       Date:  2016-01-19       Impact factor: 4.345

Review 5.  RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.

Authors:  Eunice L Lozada-Delgado; Nilmary Grafals-Ruiz; Pablo E Vivas-Mejía
Journal:  Life Sci       Date:  2017-08-31       Impact factor: 5.037

6.  Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.

Authors:  Jesper B Bramsen; Jørgen Kjems
Journal:  Front Genet       Date:  2012-08-20       Impact factor: 4.599

7.  A screen of chemical modifications identifies position-specific modification by UNA to most potently reduce siRNA off-target effects.

Authors:  Jesper B Bramsen; Malgorzata M Pakula; Thomas B Hansen; Claus Bus; Niels Langkjær; Dalibor Odadzic; Romualdas Smicius; Suzy L Wengel; Jyoti Chattopadhyaya; Joachim W Engels; Piet Herdewijn; Jesper Wengel; Jørgen Kjems
Journal:  Nucleic Acids Res       Date:  2010-05-07       Impact factor: 16.971

8.  Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy.

Authors:  Zong-Xia Lu; Li-Ting Liu; Xian-Rong Qi
Journal:  Int J Nanomedicine       Date:  2011-08-11

9.  A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity.

Authors:  Jesper B Bramsen; Maria B Laursen; Anne F Nielsen; Thomas B Hansen; Claus Bus; Niels Langkjaer; B Ravindra Babu; Torben Højland; Mikhail Abramov; Arthur Van Aerschot; Dalibor Odadzic; Romualdas Smicius; Jens Haas; Cordula Andree; Jharna Barman; Malgorzata Wenska; Puneet Srivastava; Chuanzheng Zhou; Dmytro Honcharenko; Simone Hess; Elke Müller; Georgii V Bobkov; Sergey N Mikhailov; Eugenio Fava; Thomas F Meyer; Jyoti Chattopadhyaya; Marino Zerial; Joachim W Engels; Piet Herdewijn; Jesper Wengel; Jørgen Kjems
Journal:  Nucleic Acids Res       Date:  2009-03-12       Impact factor: 16.971

10.  siRNA-optimized Modifications for Enhanced In Vivo Activity.

Authors:  Denise M Kenski; Gabor Butora; Aarron T Willingham; Abby J Cooper; Wenlang Fu; Ning Qi; Ferdie Soriano; Ian W Davies; W Michael Flanagan
Journal:  Mol Ther Nucleic Acids       Date:  2012-01-24       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.